AES vs EMA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The AES Corporation exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. While the stock appears undervalued based on a low P/E of 9.63 and forward P/E of 6.16 relative to sector peers, and trades near its Graham Number of $13.44, high leverage (Debt/Equity: 3.03) and weak liquidity (Current Ratio: 0.72) raise concerns. Strong recent earnings growth (YoY +25.3%, Q/Q +26.8%) and a solid dividend yield of 4.82% provide support, but inconsistent quarterly earnings beats (1 of last 4) and bearish technical trend (10/100) limit upside conviction. Analysts recommend a 'buy' with a target of $15.21, implying modest upside, aligning with a neutral stance.
Emera Inc. presents a conflicting profile: while it maintains a stable Piotroski F-Score of 4/9 and strong revenue growth, it is plagued by a severe collapse in earnings (-56.9% YoY). The stock is currently trading at a significant premium to both its Graham Number ($40.09) and its growth-based intrinsic value ($17.29). While the company outperforms sector averages in profit margins and ROE, critical liquidity risks are evident in the current and quick ratios. The overall outlook is tempered by a highly bearish technical trend and a dangerously high dividend payout ratio.
Compare Another Pair
Related Comparisons
AES vs EMA: Head-to-Head Comparison
This page compares The AES Corporation (AES) and Emera Incorporated (EMA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.